Serotonin signaling plays key roles in augmentation of pancreatic b-cell function during pregnancy. Increased expression of tryptophan hydroxylase 1 (Tph1), a rate-limiting enzyme for serotonin synthesis by lactogenic hormones, is involved in this phenomenon. To investigate its mechanisms, we here performed 5 0 -RACE and identified b-cell-specific transcription initiation sites for Tph1. Prolactin enhanced the expression of mRNA containing these exons; however, reporter gene plasmids containing the proximal 5 0 -flanking region of these exons did not show prolactin responsiveness in MIN6 cells.
Introduction
Glucose homeostasis is maintained through the coordinate activities of the insulin-producing pancreas and glucose-storing tissues, including muscle, liver, and adipose tissue. Pancreatic b cells respond to fluctuations in blood glucose to secrete appropriate amounts of insulin; therefore, disruption of insulin release causes glucose intolerance. The capacity of insulin secretion from a pancreas is governed by its b-cell mass and the capacity of each b cell to release insulin. Type 1 diabetes is characterized as insulitis triggered by an autoimmune disorder against b cells, leading to an absolute defect of insulin release. In type 2 diabetes, insufficient insulin secretion to compensate for insulin resistance causes hyperglycemia. Previous studies showed that a reduction in b-cell mass was observed in type 1 as well as type 2 diabetic patients, suggesting that the preservation of or increase in b-cell mass is a promising approach to maintain normoglycemia (Butler et al. 2003 , Meier et al. 2005 . Whereas islet mass increases during the prenatal and neonatal period, the appearance of proliferation markers in b cells decreases with ageing (Meier et al. 2005 , 2008 , Gregg et al. 2012 , Saisho et al. 2013 . Although pancreas or islet transplantation would be an effective approach to augment b-cell mass, there is limited availability of pancreata for transplantation.
Placental lactogens induce glucose intolerance during pregnancy, which leads to dramatic increases in insulin release to maintain blood glucose levels. Pathological analysis of pregnant rodent models demonstrated that b-cell mass increases daily (Buchanan & Xiang 2005 , Rieck & Kaestner 2010 . Numerous studies have shown that the prolactin receptor plays an important role in the augmentation of b-cell function in pregnant rodent models. Indeed, heterozygous prolactin receptor knockout mice exhibited mild glucose intolerance and failed increase in b-cell mass during pregnancy (Huang et al. 2009 , Hughes & Huang 2011 . In addition, treatment with prolactin or placental lactogens evoked b-cell proliferation in isolated islets. These data suggest that mechanisms of b-cell compensation during pregnancy are different from those during overnutrition (Chang-Chen et al. 2008) . Recently, our group showed that serotonin (5-hydroxytryptamine (5-HT)) is highly expressed in mouse and human islets during pregnancy and contributes to increases of b-cell proliferation as well as insulin secretion (Kim et al. 2010) . At the middle stage of pregnancy, expression of a rate-limiting enzyme for 5-HT synthesis, tryptophan hydroxylase 1 (Tph1), is upregulated w500-fold. This dramatic change of gene expression results in the enhanced expression of 5-HT in islets during pregnancy. The treatment of isolated mouse islets with 5-HT increased the proliferation of b cells, at least in part through the Ga(q)-linked 5-HT receptor called the 5-HT2b receptor (Kim et al. 2010) . In addition, activation of the inotropic 5-HT receptor, 5-HT3a receptor, results in enhanced glucose-induced Ca influx, which plays a central role in enhanced glucose-stimulating insulin secretion during pregnancy (Ohara-Imaizumi et al. 2013) . Inhibition of 5-HT synthesis by dietary restriction of tryptophan or a Tph1 inhibitor induced glucose intolerance in pregnant mice without affecting insulin sensitivity (Kim et al. 2010) . The expression of Tph1 was enhanced by prolactin; however, its precise mechanism has not been fully elucidated (Kim et al. 2010 , Schraenen et al. 2010 .
The mechanism involved in the prolactin-induced expression of Tph1 in b cells is one of the key mechanisms that compensate for insulin resistance during pregnancy. In this study we investigated the mechanisms by which prolactin regulates Tph1 mRNA expression in a b-cell line and in islets from pregnant mice.
Materials and methods

Cell culture and islet isolation
MIN6 mouse insulinoma cells were cultured in DMEM supplemented with 15% (v/v) FCS, 10 mM HEPES, and 1% (v/v) penicillin and streptomycin (Life Technologies) under 5% CO 2 at 37 8C. bTC3 mouse insulinoma cells were cultured in DMEM supplemented with 15% (v/v) horse serum, 2.5% (v/v) FCS, and 1% (v/v) penicillin and streptomycin. Isolation of mouse islets was performed as described previously (Iwashita et al. 2007) . For chromatin immunoprecipitation (ChIP) analysis, islets were isolated from non-pregnant and pregnant mice at gestational age (G) 12.5 days. Mouse islets were cultured in RPMI1640 supplemented with 10% (v/v) FCS, and 1% (v/v) penicillin and streptomycin. After pretreatment with or without 100 mM AG490 (a tyrosine kinase inhibitor of JAK2) (Sigma-Aldrich), 10 mM U0126 (a selective inhibitor of MEK1/2) (WAKO, Tokyo, Japan), or 50 mM LY-294002 (an inhibitor of PI3Ks) (Cell Signaling, Tokyo, Japan) for 30 min, MIN6 cells, bTC3 cells, or mouse islets were stimulated with or without 44.2 nM of prolactin (R&D Systems, Minneapolis, MN, USA) for the indicated times. 
Quantitative RT-PCR
Plasmid constructs
Upstream sequences of various lengths of mouse Tph1 exon 1 or exon 2 were amplified by PCR using each primer set as described in the Supplementary Table, see section on supplementary data given at the end of this article, and subcloned into the reporter gene plasmid pFox Luc One (pFLO) (Smith et al. 1999) or pGL3 (Promega). Two putative Stat5-binding elements and a mutated element were constructed by annealing two oligonucleotides (GAS-A forward: 5 0 -GATCTGTCCCCAGCTCTTCCCAGAA-AGCCCTGAGGTG-3 0 , reverse: 5 0 -GATCCACCTCAGGGC-TTTCTGGGAAGAGCTGGGGACA-3 0 , GAS-B forward:
. 6!GAS-A, 6!GAS-B, or 6!GAS-A Mutation were subcloned into the reporter gene plasmid containing the prolactin minimal promoter, pFLO-Prl (Deering et al. 2009) , and pFLO-Tph1 ex1b-760bp via BglII and BamHI restriction sites as described in a previous report (Smith et al. 1999) . The reporter gene plasmid containing upstream activating sequences for galactose and TATA box (UAS-TATA-Luciferase) was a generous gift from Dr Kajimura (University of San Francisco) (Seale et al. 2007 ). The Stat5A cDNA sequence was amplified using the primer set described in Supplementary Electrophoretic mobility shift assay MIN6 cells were seeded in 10-cm dishes, and isolated nuclear extracts were subjected to electrophoretic mobility shift assay (EMSA) according to the procedure described previously (Sadowski et al. 1993 ). The GAS-A oligonucleotides (5 0 -GATCTGTCCCCAGCTCTTCCCAGAAAGCCCT-GAGGTG-3 0 ) and GAS-A Mutation oligonucleotides (5 0 -GATCTGTCCCCAGCTCTGACCAATAAGCCCTGAG-GTG-3 0 ) labeled by IRDye700 were purchased from Integrated DNA Technologies (Coralville, IA, USA). One microgram of nuclear protein extract was incubated in EMSA buffer (10 mM HEPES (pH 7.9), 75 mM KCl, 2.5 mM MgCl 2 , 0.1 mM EDTA, 1 mM DTT, 3% (w/v) Ficoll, 0.05% (w/w) poly(dI-dC), 7.35 mM BSA) for 10 min at room temperature with 5 ml rabbit serum or 5 ml of a STAT5 antibody (Santa Cruz). For competitive analysis, we used a 50-fold or 100-fold excess of non-labeled oligonucleotides (5 0 -CTGTCGTTTCCTGGAATTGGCCATACCTGGAAGAG-GCC-3 0 ). Reaction mixtures were electrophoresed through a 5% non-denaturing polyacrylamide gel. After electrophoresis, the gels were dried and scanned by the Odyssey infrared imaging system (LI-COR, Lincoln, NE, USA).
ChIP assay
MIN6 cells (3!10 7 ) were treated with trypsin/EDTA, and w150 mouse islets were suspended in Ca 2C -free Hank's balanced salt solution for 30 min at 37 8C, followed by adjusting to 1 mM EGTA for dissociation, and resuspended in PBS. DNA-protein complexes were cross-linked by 1% (w/v) formaldehyde and incubated at room temperature for 10 min, followed by the addition of 0.2 M glycine to stop the cross-linking reaction. The cells were washed twice with ice-cold PBS and three times with 10 ml of MC lysis buffer (10 mM Tris-Cl (pH 7.5), 10 mM NaCl 2 , 3 mM MgCl 2 , and 0.5% (v/v) NP-40). The pellet was resuspended in 1 ml of MNase buffer (10 mM Tris-Cl (pH7.5), 10 mM NaCl, 3 mM MgCl 2 , 1 mM CaCl 2 , 4% (v/v) NP-40, and 1 mM phenylmethylsulphonyl fluoride (PMSF)), to a final volume of 1.5 ml. DNA was fragmented by 10-100 U of Micrococcal Nuclease for 10 min at 37 8C. To stop the enzymatic reaction, the sample was adjusted to 3 mM EGTA, 1 mM PMSF, 1!Halt protease and phosphatase inhibitor cocktail (Life Technologies), 1% (v/v) SDS and 200 mM NaCl. The nuclei were subsequently sheared on ice with 15 pulses (MIN6 cells) or 40 pulses (mouse islets) of 5 s sonication with a cooling period 15 s, using Sonicator (Qsonica, Newtown, CT, USA). Supernatants were diluted 1:5 by adding FA lysis buffer (50 mM HEPES adjusted to pH 7.5 with KOH, 150 mM NaCl, 1 mM EDTA, 1% (v/v) TritonX-100, 0.1% (w/v) sodium deoxycholate, and 0.1% (v/v) SDS) containing 1 mM PMSF and 1!Halt protease and phosphatase inhibitor cocktail. Then 50-100 ml of protein A/G PLUS-Agarose beads (Santa Cruz) were added and incubated at 4 8C for 4 h to preclean the chromatin. After this incubation, the samples were centrifuged at 300 g for 5 min at room temperature, and 10% of the supernatant was taken as the input. The samples were incubated with protein A/G PLUS-Agarose beads (50-100 ml) conjugated to 1 mg of a STAT5 antibody (sc-835x; Santa Cruz) overnight at 4 8C on an end-over-end rotator. The STAT5 antibody-conjugated beads were washed and the chromatin was eluted by 100 ml of ChIP elution buffer. Two percent (w/w) of Pronase (Roche) was added and the eluted chromatin fragments were reverse cross-linked by incubation at 42 8C for 2 h, followed by incubation at 65 8C for 6 h. The DNA was purified using the QIAquick PCR purification kit (Qiagen) according to the manufacturer's instructions. The relative amount of Stat5 binding was determined by PCR using the primers specific for the mouse Tph1 promoter ( 
Mouse experiments
Floxed Stat5 mice were a generous gift from Dr Lothar Hennighausen (National Institute of Health, USA) (Lee et al. 2007) . Tamoxifen-inducible islet-specific Stat5 knockout mice were generated by crossing Pdx1-Cre-ER mice with floxed Stat5 mice (Lee et al. 2007) . Tamoxifen (75 mg/kg body weight) or corn oil was injected intraperitoneally into 6-week-old mice. These mice were mated at 12 weeks old, and sacrificed at G12.5. After perfusion with 4% (w/v) paraformaldehyde, pancreata were isolated from the mice and embedded in paraffin. Immunofluorescent staining was performed using an anti-5-HT antibody (1:1000, Immunostar, Hudson, WI, USA), an anti-Ki-67 antibody (1:200, BD Biosciences, Tokyo, Japan), and an anti-insulin antibody (1:1000 dilution, Dako, Tokyo, Japan) as described previously (Kim et al. 2010) . Primary antibodies were detected with Alexa-fluor 488-and 555-conjugated secondary antibodies and visualized using TCS-SP5 (Leica, Tokyo, Japan) and the Leica application Suite Version 2.6.0 software. Animal experiments were performed with the approval of the Ethics Review Committee for Animal Experimentation of Juntendo University and Korea Advanced Institute of Science and Technology.
Statistical analysis
All data are presented as the meansGS.E.M. The Student's t-test was used for comparisons involving two conditions. One-way ANOVA followed by the Tukey-Kramer test, or two-way ANOVA was used for comparisons among more than three groups. P!0.05 was considered to indicate a statistically significant difference between two groups.
Results
Prolactin-induced Tph1 expression in the mouse insulinoma cell line MIN6
As the first step toward investigating the mechanisms of Tph1 expression in b cells, we evaluated the prolactininduced expression of Tph1 in mouse insulinoma cell lines MIN6 and bTC3. In MIN6 cells, prolactin induced an eightfold increase in expression of Tph1 mRNA (Fig. 1A) .
On the other hand, although bTC3 cells also expressed Tph1 mRNA, prolactin did not alter its expression. Thus, we used MIN6 cells to investigate prolactin-responsive Tph1 expression. It is of note that the expression level of the prolactin receptor was w100 times lower in bTC3 cells than in MIN6 cells (Fig. 1B) . According to the NCBI database (http://www.ncbi.nlm.nih.gov/), the mouse Tph1 gene has at least two alternatively spliced exon 1s (shown as exon 1a and exon 1c in Fig. 2A ). To identify the Tph1 gene transcripts that are expressed in b cells, we performed 5 0 -RACE using RNA isolated from MIN6 cells, and found a transcript encoding another form of exon 1 located between 2 exons (shown as exon 1b in Fig. 2A and B) . Using primers to identify the expression of transcripts encoding each exon 1 (1a, 1b, and 1c), we performed RT-PCR ( Fig. 2A) . In MIN6 cells and islets, expression of transcripts encoding exon 1b and 1c, but not that encoding exon 1a were observed and the expression of both of these transcripts was increased by prolactin ( Fig. 2C and D) . To investigate whether the proximal 5 0 -flanking region of each exon contains promoter activity, we cloned various lengths of the 5 0 -flanking region of exon 1a, and exon 1bC1c, and inserted them upstream of the firefly luciferase gene in a reporter gene construct ( Fig. 3A and B) . After transfection of a series of constructs in MIN6 cells, we evaluated their transcriptional activity by the luciferase assay and found that the plasmids containing the 5 0 flanking region of exon 1bC1c have promoter activity in MIN6 cells, but the plasmids containing the 5 0 -flanking region of exon 1a did not show any promoter activity (Fig. 3A) . However, stimulation with prolactin did not increase the promoter activity of any of the constructs that we generated (Fig. 3A and B) . These results suggest that prolactin responsive elements are not located in the proximal 5 0 -flanking region of exon 1bC1c.
Prolactin-induced expression of Tph1 is disrupted by treatment with a JAK2 inhibitor
Reporter gene analyses have suggested that prolactinresponsive elements are located at a distal region from the transcription start site. Thus, we next analyzed the signaling pathway that is essential for prolactin-responsive Tph1 expression. Prolactin binds the prolactin receptor and drives several downstream protein kinase cascades, such as Jak2, Erk, and PI3K (Buchanan & Xiang 2005 , Bernichtein et al. 2010 . After pretreatment with an inhibitor for each cascade, we treated MIN6 cells with or without prolactin and evaluated Tph1 expression by quantitative RT-PCR (qRT-PCR). The prolactin-induced expression of Tph1 was greatly reduced by treatment with the Jak2 inhibitor AG490 and partially reduced by the selective MEK1/2 inhibitor U0126 (Fig. 4A) . On the other hand, addition of the PI3K inhibitor LY294002 increased the basal expression of Tph1; however, its expression was not altered upon treatment with prolactin, and hence resulted in decreased prolactin responsiveness. We also evaluated the effect of these inhibitors on isolated mouse islets treated with prolactin and found that Tph1 expression was attenuated by treatment with the MEK1/2 inhibitor, the PI3K inhibitor, or the JAK2 inhibitor (Fig. 4B ). These data suggest that each pathway contributes to prolactin-induced Tph1 expression in mouse islets. As activation of Jak2 plays a central role in Tph1 expression in MIN6 cells as well as in mouse islets, we further investigated the Jak2/Stat5 pathway. The prolactin receptor activates Jak2, which induces the phosphorylation and dimerization of Stat5 (Sorenson & Brelje 2009 . Dimerized Stat5 translocates from the cytosol into the nucleus and recognizes interferon g-activated sequence (GAS) (Berg 2008 , Muller et al. 2008 . Therefore, we surveyed the GAS consensus sequence in the 5 0 -flanking region of the Tph1 gene and found two sequences that perfectly match the GAS consensus sequence (GAS-A and GAS-B shown in Fig. 5A ). These sequences are located at about 9 and 6 kbp upstream of the transcription start site, respectively. To investigate whether these potential Stat5 binding regions are sufficient to exhibit prolactin responsiveness, we analyzed reporter gene constructs containing each potential Stat5 binding region upstream of a heterologous promoter, the prolactin minimal promoter. Transcriptional activity of the GAS-A plasmid, but not the GAS-B plasmid, was enhanced by treatment with prolactin in MIN6 cells (Fig. 5B) . Insertion of mutations into the GAS-A sequences disrupted prolactin-induced transactivation of the GAS-A plasmid (Fig. 5B) . Prolactin-induced transcriptional activity was disrupted by the forced expression of a dominant-negative form of Stat5A as well as by treatment with a Jak2 inhibitor ( Fig. 5C and D) . Furthermore, a reporter gene construct containing the 760 bp upstream of the 5 0 -flanking region of exon 1b showed prolactin responsiveness upon insertion of the GAS-A sequence, but not the GAS-B nor the mutated GAS-A sequence (Fig. 5E ). These data support the idea that GAS-A is a functional prolactin-responsive element that is activated by Jak2 and Stat5. Stat5A or a dominant-negative form of Stat5A were co-transfected with the 6!GAS-A plasmid into MIN6 cells. At 24 h after transfection, MIN6 cells were treated with or without 44.2 nM of prolactin for 24 h. (E) The reporter gene plasmids containing a fragment from K760 bp to C114 bp of the Tph1 gene linked to the 6!GAS-A, 6!GAS-A Mutation, or the 6!GAS-B fragment were transfected into MIN6 cells. At 24 h after transfection, the cells were incubated with or without 44.2 nM of prolactin for 24 h and harvested. Luciferase activity was standardized by the protein concentration. Luciferase activity in cells without prolactin treatment was set as 1. *P!0.05 compared with cells treated without prolactin. All experiments were repeated at least three times. All data are shown as meansGS.E.M.
Stat5 binds a potential Stat5 binding region in the Tph1 gene
To investigate the prolactin-responsive binding of Stat5 to GAS-A, we isolated nuclear proteins from MIN6 cells and performed the EMSA using sequences of the GAS-A region as a probe. The GAS-A probe identified several nuclear proteins, and the amount of these nuclear proteins bound to the GAS-A probe further increased by treatment with prolactin ( Fig. 6A and B) . The cold probe of the consensus sequence for GAS (Soldaini et al. 2000) disrupted the association between the GAS-A probe and the nuclear proteins that were recognized by the anti-serum for Stat5. On the other hand, the mutated GAS-A probe did not efficiently recognize Stat5 (Fig. 6C) . Next, we designed primers recognizing the GAS-A region and performed the ChIP assay using anti-serum for Stat5 (Fig. 7A) . Prolactin treatment enhanced the enrichment of Stat5 in the GAS-A region of MIN6 cells as well as of isolated mouse islets (Fig. 7B ). In addition, we performed ChIP analysis in islets isolated from pregnant mice and found that Stat5 recognized the GAS-A region in mouse islets during pregnancy (Fig. 7B) . As there are no GAS consensus sequences except the GAS-A sequence around this region, our results suggest that Stat5 binds to the GAS-A site in islets during pregnancy.
Prolactin increases the transcriptional activity of Stat5 through Erk and PI3K
Recently, prolactin was reported to enhance the transactivation activity of Stat5 after inducing the binding of dimerized Stat5 to GAS (Moriggl et al. 1996) . Therefore, we generated a plasmid encoding Stat5A conjugated with the DNA-binding domain (DBD) of GAL4, and cotransfected this with a reporter gene construct containing GAL4 Putative interferon-g-activated sequence identifies Stat5. (A) Sequences of the IR Dye-labeled probes and non-labeled cold probe. (B) Electrophoretic mobility shift assays (EMSAs) were performed using nuclear extracts from MIN6 cells treated with or without 44.2 nM of prolactin for 1 h. Nuclear protein-DNA complexes were resolved in 5% non-denaturing polyacrylamide gels (lanes 2-3). Competition assays were performed in the presence of a 50-fold or 100-fold molar excess of the GAS consensus sequences (lanes 4-5). The supershift assay was performed in the presence of rabbit serum (lane 6) and STAT5 antibody (lane 7). (C) Binding activity of the GAS-A probe (lanes 1-3) and the GAS-A Mutation probe (lanes 4-6) were evaluated using nuclear extracts from MIN6 cells. All experiments were repeated at least three times. 'Stat5 complex' indicates the protein and probe complex, including Stat5. 'NS' indicates a non-specific band.
binding sequences (upstream activating sequences of galactose (UASG)) into MIN6 cells. Forced expression of GAL4 DBD-Stat5A increased luciferase activity to a higher level than forced expression of the GAL4 DBD, suggesting the existence of the transactivation activity of Stat5A (Fig. 8A) . Treatment with prolactin further enhanced the transactivation activity of Stat5A in MIN6 cells, and its activity was partially attenuated by pretreatment with an MEK1/2 inhibitor or a PI3K inhibitor, but not a Jak2 inhibitor (Fig. 8B) . These results suggest that the Erk and PI3K pathways partially regulate prolactin-induced Stat5 transcriptional activity.
Serotonin expression is decreased in islets of b-cell specific Stat5-deficient mice
To confirm the contribution of Stat5 on Tph1 expression in islets, we generated tamoxifen-inducible b-cell specific Stat5-deficient mice (b-Stat5 K/O) by crossing mice expressing tamoxifen-inducible Cre driven by the mouse Pdx1 promoter and mice with floxed Stat5. After the injection of tamoxifen or corn oil, b-Stat5 K/O mice were mated, and the pancreata of the resulting pregnant mice were isolated at G12.5. Immunohistochemical analysis was then performed to evaluate the expression of 5-HT in the isolated islets. Stat5 inactivation led to a decrease in the expression of 5-HT in islets, which was accompanied with decreases in the percentage of Ki-67-positive cells among insulin-positive cells ( Fig. 9A and B) .
Discussion
Pregnancy greatly alters hormonal release patterns, causing physiological changes including insulin resistance. The insufficient compensation of insulin secretion contributes to the development of gestational diabetes. Meanwhile, numerous studies performed in pregnant mice have shown that proliferation of b cells is augmented in response to pregnancy (Zhang et al. 2010 , Demirci et al. 2012 , Jacovetti et al. 2012 . The prolactin receptor is the target of prolactin and placental lactogen, and is expressed in pancreatic b cells to contribute for augmentation of insulin release during pregnancy (Buchanan & Xiang 2005) . Although overnutrition also causes insulin resistance and an increase in islet mass, the mechanism of the b-cell proliferation is thought to be different from that which occurs during pregnancy. Pregnancy augments the Pregnant mouse islets were isolated at G12.5. Cross-liked protein-DNA complexes were immunoprecipitated with the anti-Stat5 antibody or normal rabbit IgG used as a non-specific control. Input DNA was determined using 10% of the total sample as the template. The proximal promoter region of the Alb gene was used as a negative control. All experiments were repeated at least three times. secretion of various hormones that may regulate b-cell function or survival, such as estrogen, placental lactogen, and prolactin. Previously, our group showed that prolactin increases the expression of the rate-limiting enzyme for 5-HT synthase, Tph1, and that 5-HT contributes to the increase in b-cell mass through upregulation of Ccna1, Ccnb1, and Ccnb2 (Kim et al. 2010) .
In this study, we identified the b-cell-specific transcriptional start site of Tph1 as exon 1b and exon 1c, and evaluated the precise mechanisms of prolactin-responsive Tph1 expression by reporter gene analysis. Whereas proximal 5 0 -flanking regions of exon 1b and exon 1c exhibited promoter activity in b-cells, they did not show prolactin responsiveness. Because prolactin-induced transcription of Tph1 was greatly disrupted by treatment with a Jak2 inhibitor in MIN6 cells as well as mouse islets, we analyzed potential GAS regions in the 5 0 -flanking region of exon 1s and identified the GAS-A region located 9 kb upstream of exon 1b. The GAS-A region exhibited prolactin responsiveness and was recognized by Stat5 in MIN6 cells. We did not detect the expression of mRNA containing exon 1a in MIN6 cells or in mouse islets. Consistent with the results of RT-PCR analysis, the luciferase activity of reporter gene plasmids containing the 5 0 -flanking region of exon 1a was repressed compared to that of the control reporter vector, suggesting that repressors might block the transcriptional activity of exon 1a in b cells. Although the reporter gene constructs containing the 5 0 -flanking region of exon 1a have the GAS-A region, they failed to respond to prolactin (Fig. 3A) . We speculated that this was due to the binding of repressor proteins to these constructs. To evaluate the GAS-A region in islets, we performed ChIP analysis using isolated mouse islets, and demonstrated that prolactin induced Stat5 binding on GAS-A region and that Stat5 recognized the GAS-A region in islets isolated from pregnant mice. Furthermore, we analyzed the pancreata of b-cell-specific Stat5 knockout mice that were shown to exhibit glucose intolerance (Lee et al. 2007) . During pregnancy, b-cell-specific Stat5 knockout mice demonstrated decreases of 5-HT expression and decreases in the number of Ki-67-positive cells in islets. Our results suggest that a reduction of 5-HT expression may contribute to the glucose intolerance in b-cell-specific Stat5 knockout mice.
Prolactin induces the phosphorylation and dimerization of STAT5, which increases the binding activity of STAT5 on GAS (Karnik et al. 2007 , Qian et al. 2009 . Although the C-terminal domain of Stat5 is not sufficient for the DNA binding of dimerized Stat5, it still contributes to the enhancement of transactivation in response to prolactin or growth hormone (GH) (Moriggl et al. 1996) . To assess the transactivation activity of Stat5, we generated the fusion protein GAL4 DBD-Stat5A and evaluated its transcriptional activity using a reporter gene plasmid containing UASG. GAL4 DBD-Stat5A bound UASG, and treatment with prolactin further enhanced the luciferase activity in MIN6 cells. Our results indicate that prolactin augments the transcriptional activity of Stat5 through increases of both DNA binding and transactivation activity in b cells.
Previous studies showed several mechanisms of transactivation in the C-terminal domain of Stat5. Disruption of serine phosphorylation in the C-terminal domain of Stat5 impairs prolactin and GH responsiveness (Yamashita et al. 1998 , Park et al. 2001 . Nonacidic residues of the C-terminal domain contribute to prolactin responsiveness in NIH3T3 cells (Callus & Mathey-Prevot 2000) . Litterst et al. (2003) demonstrated that an interaction between the C-terminal domain and a cofactor is important for prolactin-induced b-casein expression in HeLa cells. However, the upstream cascade of the C-terminal domain of Stat5 is not clear. Our qRT-PCR analysis showed that pretreatment with an MEK1/2 inhibitor or PI3K inhibitor partially impairs prolactin responsiveness in Tph1 expression. Reporter gene analysis using GAL4 DBD-Stat5 demonstrated that prolactin-induced enhancement of the transactivation of Stat5 was disrupted by treatment with an MEK1/2 inhibitor or PI3K inhibitor, but not with a Jak2 inhibitor. These results suggest that the Erk and PI3K cascades enhance the transactivation of Stat5 in b cells (Fig. 10) . Schraenen et al. (2010) showed that treatment with an MEK1/2 inhibitor or PI3K inhibitor did not impair prolactin-induced Tph1 expression in MIN6 cells. MIN6 cells are heterogeneous and can be subcloned into several populations with slightly different characteristics (Lilla et al. 2003 , Yamato et al. 2013 . The discrepancy between our results and those of Schraenen et al. might hence be a result of using different subclones of MIN6 cells, in which the expression profiles of cofactors may differ. Therefore, the signaling cascade that utilizes Erk or PI3K appears to contribute to the prolactininduced enhancement of Stat5 transactivation in the MIN6 cell subclone that was used in our present study, and importantly, in mouse islets. Further experiments should be performed to address the relationship between the Stat5, Erk, and PI3K pathways for Tph1 expression. Satyanaryana et al. showed that several GASs are located around the Igf1 gene and regulate the expression of Igf1 in response to GH, suggesting that multiple GASs may contribute to Tph1 expression in islets (Eleswarapu et al. 2008) . The recently developed tool for ChIP analysis linked to next-generation DNA sequencing should allow us to identify numerous cis-elements in the whole genome. This technique should provide more comprehensive data on the role of Stat5 in Tph1 expression, as well as comprehensive information on the mechanism by which prolactin regulates the compensation of b cells during pregnancy. Further studies are required to fully clarify the role of 5-HT in b-cell proliferation, which should contribute to developing new strategies to increase b-cell mass for the treatment of type 1 as well as type 2 diabetes. Proposed model of 5-HT synthesis in response to prolactin in b cells during pregnancy. Prolactin binds to its receptor on b cells, which induces the phosphorylation of Jak2 and Stat5. The dimerized Stat5 is translocated into the nucleus and binds to the GAS-A region in the Thp1 promoter to induce Tph1 expression. Stat5-induced Tph1 expression is partially mediated by Erk and PI3K in response to prolactin. Tph1 is the rate-limiting enzyme for the synthesis of 5-HT that contributes to b-cell proliferation during pregnancy. 5-HTP, 5-hydroxytryptophan.
